Walgreen Company February Sales Rise 5% to Nearly $6.1 Billion

Walgreen (NYSE: WAG  ) announced today that February sales were $6.05 billion, which represented a 5% improvement over the $5.76 billion posted in February of 2013. The company said factors including the weather and the introduction of generics held the number down.

In total, comparable-store sales-- a metric measuring sales at stores that have been open for more than a year -- at the drugstore chain were up 4.5% in the month, but the company noted its sales were negatively affected by 0.9 percentage points as a result of generic drugs which were introduced in the previous 12 months. In addition, Walgreen said the lower number of flu incidences reduced comparable sales by an additional 0.4 percentage points in February.

The company said 7.7 million flu shots were administered at pharmacies and clinics in the flu season to date, compared to 7.0 million last year. This helped bump up pharmacy sales numbers.

February sales at comparable Walgreens pharmacies rose by 6.1%, and total pharmacy sales grew by 6.7% year over year. Once more the company highlighted its comparable store sales were affected by generic drug introductions, which resulted in a 1.4-percentage-point reduction in pharmacy sales figures. In addition, the lessened flu incidents negatively affected comparable pharmacy sales by 0.7 percentage points. Pharmacy sales accounted for 62.9% of total sales for the month.

The company said total front-end sales increased 3% year over year.

In total, Walgreen noted it saw sales rise to $19.6 billion for the second quarter of its 2014 fiscal year (December through February), which represented a 5.2% increase over the $18.7 billion seen in the second quarter of 2013. Its comparable-store sales rose 4.5%, but the company highlighted its front-end sales were negatively affected by 0.6 percentage points by severe weather and that prescriptions filled at comparable stores were negatively impacted by 0.8 percentage points because of the weather. In addition Walgreen noted it saw increases in selling, general, and administrative expenses resulting from the severe weather.

The company concluded its release by revealing it has seen its total sales for the first six months of its 2014 fiscal year rise from $36 billion last year to $38 billion this year, an increase of 5.5%.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2865211, ~/Articles/ArticleHandler.aspx, 11/26/2014 2:35:52 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement